Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339664 · ClinicalTrials.gov registry record
Analyses of Human Samples Collected in Clinical Trials
A clinical trial of Prostate Cancer and Neoplasm Metastasis, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,579
- Enrollment target
- 17
- Study locations
NCT00339664 is a study of Prostate Cancer and Neoplasm Metastasis that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,579 participants, above the 605-participant average among 735 other Prostate Cancer trials with a reported enrollment target (326% higher). The trial reports 17 study locations across 10 states.
The verdict
NCT00339664, a study of Prostate Cancer and Neoplasm Metastasis, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,579 participants
- Enrollment target
- 17
- Study locations
Study Summary
Cancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes. The purpose of this study is to conduct further analyses on these existing samples from clinical trials that are being performed outside of, but in collaboration with, the National Cancer Institute.
Conditions Studied
Study Locations (17)
Maryland
- University of Maryland, Baltimore - Baltimore
- Johns Hopkins Medical Center - Baltimore
- Sidney Kimmel Comprehensive Cancer Center - Baltimore
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Pennsylvania
- University of Maryland at Amish Research Clinic, Lancaster - Lancaster
- Abramson Cancer Center, University of Pennsylvania - Philadelphia
- Hillman Cancer Center at University of Pittsburg Cancer Institute - Pittsburgh
Virginia
- McGuire Veterans Administration Medical Center - Richmond
- Massey Cancer Center, Virginia Commonwealth University - Richmond
Other
- Leiden University Medical Center - Leiden
- Erasmus Medical Center - Rotterdam
District of Columbia
- Childrens National Medical Center - Washington D.C.
Florida
- H. Lee Moffitt Cancer Center & Research Institute - Tampa
Illinois
- University of Chicago - Chicago
Minnesota
- Mayo Clinic, Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,579 participants |
| Start Date | 2003-07-02 |
| Est. Completion | 2020-03-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00339664
The ClinicalTrials.gov registry entry for NCT00339664 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,579 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 605-participant average among 735 other Prostate Cancer trials with a reported enrollment target (326% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00339664 reports 17 study locations spanning 10 distinct geographic areas - top geographies include Maryland, Pennsylvania, Virginia.
Frequently Asked Questions
What is clinical trial NCT00339664 about?
NCT00339664 is a clinical study titled "Analyses of Human Samples Collected in Clinical Trials". Cancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes. The purpose of this study is to conduct further analyses on these existing samples from clinical trials that are being performed outside of, but in collabo...
What is the current status of trial NCT00339664?
This trial is currently completed. The enrollment target is 2,579 participants. The study started on 2003-07-02. Estimated completion is 2020-03-26.
What conditions does trial NCT00339664 study?
This clinical trial studies the following conditions: Prostate Cancer, Neoplasm Metastasis, Leukemia, Myeloid, Leukemia, Lymphoid.
Who is sponsoring clinical trial NCT00339664?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00339664 being conducted?
This trial has 17 study locations across District of Columbia, Florida, Illinois, Maryland, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.